FIELD: medicine; nephrology; cardiology.
SUBSTANCE: invention can be used to assess the risk of developing cardiovascular complications in patients with diabetic nephropathy at all stages of chronic kidney disease. Blood serum is analyzed by enzyme immunoassay. Determining the level of advanced glycation products (AGEs). If the value of AGEs is up to 5,250 ng/ml, a low risk is stated, from 5,250 to 10,600 ng/ml—a moderate risk, from 10,600 ng/ml—a high risk of developing cardiovascular complications.
EFFECT: method enables assessing the risk of developing cardiovascular complications in patients with diabetic nephropathy at all stages of chronic kidney disease by determining the level of AGEs in blood of patients, which enables to increase the accuracy of early diagnosis of cardiovascular accidents in these patients.
1 cl, 3 tbl, 1 ex
